Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

NCT05158894 · clinicaltrials.gov ↗
RECRUITING
Status
1884
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie